Pharmaceutics (Oct 2022)

Advances of Cobalt Nanomaterials as Anti-Infection Agents, Drug Carriers, and Immunomodulators for Potential Infectious Disease Treatment

  • Yuhe Ma,
  • Wensen Lin,
  • Yongdui Ruan,
  • Hongmei Lu,
  • Shuhao Fan,
  • Dongsheng Chen,
  • Yuhe Huang,
  • Tangxin Zhang,
  • Jiang Pi,
  • Jun-Fa Xu

DOI
https://doi.org/10.3390/pharmaceutics14112351
Journal volume & issue
Vol. 14, no. 11
p. 2351

Abstract

Read online

Infectious diseases remain the most serious public health issue, which requires the development of more effective strategies for infectious control. As a kind of ultra-trace element, cobalt is essential to the metabolism of different organisms. In recent decades, nanotechnology has attracted increasing attention worldwide due to its wide application in different areas, including medicine. Based on the important biological roles of cobalt, cobalt nanomaterials have recently been widely developed for their attractive biomedical applications. With advantages such as low costs in preparation, hypotoxicity, photothermal conversion abilities, and high drug loading ability, cobalt nanomaterials have been proven to show promising potential in anticancer and anti-infection treatment. In this review, we summarize the characters of cobalt nanomaterials, followed by the advances in their biological functions and mechanisms. More importantly, we emphatically discuss the potential of cobalt nanomaterials as anti-infectious agents, drug carriers, and immunomodulators for anti-infection treatments, which might be helpful to facilitate progress in future research of anti-infection therapy.

Keywords